Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocuphire Pharma, Inc. - Common Stock
(NQ:
OCUP
)
1.170
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocuphire Pharma, Inc. - Common Stock
< Previous
1
2
3
4
Next >
53 Biggest Movers From Yesterday
March 30, 2022
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 29, 2022
Gainers IGM Biosciences (NASDAQ:IGMS) shares rose 114.8% to $32.2 during Tuesday's regular session. IGM Biosciences's stock is trading at a volume of 31.6 million...
Via
Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
March 29, 2022
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (...
Via
Benzinga
Ocuphire Pharma's Shares Fall Despite Positive Data From Registrational Phase 3 Trial Of Nyxol
March 29, 2022
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 31, 2022
Gainers Madrigal Pharmaceuticals (NASDAQ:MDGL) shares rose 14.9% to $64.8 during Monday's pre-market session. The market value of their outstanding shares is at $1.1...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 03, 2022
Gainers Immix Biopharma (NASDAQ:IMMX) shares increased by 61.5% to $5.75 during Monday's pre-market session. The company's market cap stands at $43.5 million....
Via
Benzinga
18 Stocks Moving in Monday's Pre-Market Session
January 03, 2022
Gainers Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) rose 41.6% to $3.13 in pre-market trading after gaining around 8% on Friday. Armstrong Flooring, Inc. (NYSE: AFI...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 06, 2021
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD
Via
Benzinga
Mid-Afternoon Market Update: Dow Falls 75 Points; Biofrontera Shares Spike Higher
November 24, 2021
Toward the end of trading Wednesday, the Dow traded down 0.21% to 35,738.42 while the NASDAQ rose 0.06% to 15,784.86. The S&P also rose, gaining 0.01% to 4,690.76. The U....
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 24, 2021
Gainers Biofrontera (NASDAQ:BFRI) shares ...
Via
Benzinga
68 Biggest Movers From Wednesday
November 26, 2021
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share. Longeveron Inc. (...
Via
Benzinga
Topics
Initial Public Offering
Mid-Day Market Update: Gap Drops Following Downbeat Q3 Results; Ocuphire Pharma Shares Jump
November 24, 2021
Midway through trading Wednesday, the Dow traded down 0.28% to 35,714.19 while the NASDAQ fell 0.29% to 15,729.96. The S&P also fell, dropping 0.20% to 4,681.42. The U.S. has...
Via
Benzinga
Topics
Stocks
40 Stocks Moving In Wednesday's Mid-Day Session
November 24, 2021
Gainers Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target. Longeveron Inc...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 24, 2021
November 24, 2021
Upgrades For Aegon NV (NYSE:...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 24, 2021
Gainers Ocuphire Pharma (NASDAQ:OCUP) stock rose 78.73% to $6.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $107.6...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 24, 2021
We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
November 18, 2021
Gainers NeuroOne Medical Tech (NASDAQ:NMTC...
Via
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 06, 2021
Gainers TransCode Therapeutics (NASDAQ:RNAZ
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 20, 2021
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million....
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 03, 2021
Gainers Enveric Biosciences (NASDAQ:ENVB...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 13, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
August 06, 2021
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares rose 35.4% to $4.66 in pre-market trading after the company reported an Agreement to acquire exclusive rights for assignment of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 05, 2021
Gainers Sensus Healthcare (NASDAQ:SRTS) ...
Via
Benzinga
72 Biggest Movers From Yesterday
July 01, 2021
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share. Cuentas Inc. (NASDAQ: CUEN...
Via
Benzinga
Topics
Initial Public Offering
51 Stocks Moving In Wednesday's Mid-Day Session
June 30, 2021
Gainers Cuentas Inc. (NASDAQ: CUEN) shares jumped 176.6% to $7.69. The stock spiked following a press release saying "WaveMax to Implement the World's First Shared Wifi6...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 30, 2021
Gainers Ocuphire Pharma (NASDAQ:OCUP) shares increased by 63.57% to $7.77 during Wednesday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Ocuphire Pharma Stock Surges After Nyxol Combo Treatment Meets Study Endpoints In Presbyopic Patients
June 30, 2021
Ocuphire Pharma Inc (NASDAQ: OCUP) announced data from the VEGA-1 Phase 2 trial evaluating the efficacy and safety of Nyxol in combination with low-dose pilocarpine (LDP) in...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today